1.
Layno EB, Bronsther R. Diagnosis and
Treatment of Alzheimer’s
Disease: An Update. Dela J Public Health 2021; 7: 74-85.
2.
Amartya De, Dr. Bala N. N, Gupta PD.
Alzheimer’s Disease and its
Management. International National Journal of Research in Pharmaceutical and
biomedical science 2011; 2: 1439-43.
3.
Passeri E, Elkhoury K, Morsink M, Broersen
K, Linder M, Tamayol A, et al. Alzheimer’s
Disease: Treatment Strategies and Their Limitations. Int. J. Mol. Sci 2022; 23:
13954.
4.
WHO fact on dementia proving key fact and
information. 15 March 2023. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.
5.
Alzheimer’s disease facts and figures.
Alzheimer’s Association. 2023;19: 1598-1695 Available from: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.13016.
6.
Alzheimer’s
disease facts and figures. Alzheimer’s Association. 2021; 17: 327- 406. Available
from: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12328
7.
Alzheimer’s disease facts and figures.
Alzheimer’s Association. 2022; 18: 700-789. Available from: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.12638
8.
Alzheimer’s disease in People With Down
syndrome. An Official website of the United state government. National
Institute of Agening. 2020 [Content reviewed: 2020 November 30]. Available
from: https://www.nia.nih.gov/health/alzheimers-causes-and-risk-factors/alzheimers-disease-people-down-syndrome#learn-about-alzheimer-s-disease-research-opportunities.
9.
Balingit A, Ames H. What is the
relationship between Down syndrome and Alzheimer’s
disease? Medical News Today. Medically reviewed on 2023, September. Available
from: https://www.medicalnewstoday.com/articles/down-syndrome-and-alzheimers#summary.
10.
Reitz C, Brayne C, Mayeu M. Epidemiology
of Alzheimer disease. Nat Rev Neurol 2011; 7: 137-52.
11.
Picanço LCDS, Ozela PF, Brito MDFDB,
Pinheiro AA, Padilha EC, Braga FS, et al. Alzheimer’s Disease: A Review from
the Pathophysiology to Diagnosis, New Perspectives for Pharmacological
Treatment. Curr Med Chem 2018; 25: 3141-3159.
12.
Monczor M. Diagnosis and Treatment of
Alzheimer’s Disease. Curr. Med.
Chem 2005; 5: 5-13.
13.
Kamboj P, Dr. Thakur AK, Goswami K, Ahuja
K. Pathophysiology and management of alzheimer’s
disease: an overview. J Anal Pharm Res 2018; 9: 226-235.
14.
Coleman M, Sheppard O. Alzheimer’s
Disease: Etiology, Neuropathology and Pathogenesis. In Alzheimer’s Disease:
Drug Discovery [Internet]. Brisbane (AU): Exon Publications; 2020. Chapter 1.
Available from: https://exonpublications.com/index.php/exon/article/view/252.
15.
Khan MM,
Ahsan F, Ahmad U, Akhtar J, Badruddeen, Md. Mujahid. Alzheimer disease:
A Review. WJPPS 2016; 5: 649-666.
16.
Sultan S, Alhammadi M, Hafiz AH, Alshareef
A, Huthali RK A1, Jahdali AH A1, Barakati AM A1. An Update on Treatment of
Alzheimer disease- A Literature Review. EJPMR 2018; 5: 9-18.
17.
Breijyeh Z, Karaman R. Comprehensive
Review on Alzheimer’s Disease: Causes and
Treatment. Molecules 2020; 25: 5789.
18.
Chen ZR , Huang JB, Yang SL, Hong FF. Role
of Cholinergic Signaling in Alzheimer’s
Disease. Molecules 2022; 27:1816.
19.
Vieira THF, Guimaraes EM, Silva FR,
Ribeiro FM. Alzheimer’s
disease: Targeting the Cholinergic System. Curr Neuropharmacol 2016; 14:
101-15.
20.
Hampel H, Mesulam MM, Cuello AC,
Khachaturian AS, Vergallo A, Farlow MR, et al. Revisiting the Cholinergic
Hypothesis in Alzheimer’s
Disease: Emerging Evidence from Translational and Clinical Research. J Prev
Alzheimers Dis 2019; 6: 2-15.
21.
Zhao Y, Zhao B. Oxidative Stress and the
Pathogenesis of Alzheimer’s
Disease. Oxid Med Cell Longev 2013; 2013: 316523.
22.
Gella A, Durany N. Oxidative stress in
Alzheimer disease. Cell Adh Migr 2009; 3: 88–93.
23.
Kumar A, Sidhu J, Goyal A, Tsao JW.
Alzheimer Disease. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls
Publishing; 2025 Jan [last update 2024 Feb 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499922/.
24.
Bruno P. Imbimbo, Lombard J, Pomara N.
Pathophysiology of Alzheimer’s
Disease. Neuroimag Clin N Am 2006; 15: 727-53.
25.
Layno EB, Bronsther R. Diagnosis and
Treatment of Alzheimer’s
Disease: An Update. Dela J Public Health
2021; 7: 74-85.
26.
Alzheimer's disease facts and figures.
Alzheimer’s Association. Alzheimer’s & Dementia. 2023;19(4): 1598-1695.
Available from: https://alz-journals.onlinelibrary.wiley.com/doi/abs/10.1002/alz.13016.
27.
Afzal S, Maqsood M, Khan U, Mehmood I,
Nawaz H, Aadil F. Alzheimer Disease Detection Techniques and Methods: A Review.
IJIMAI 2021; 6: 26-38.
28.
Shoukry S AL, Rassem TT H, Makbol NNM
Alzheimer’s Diseases Detection by
Using Deep Learning Algorithms: A Mini-Review. IEEE Access 2020; 8:
77131-77141.
29.
Janeiro MH, Ardanaz CG, Sevill NS, Dong J
Erice MC, Solas M, Puerta E,et,al. Biomarkers in Alzheimer’s
disease. Adv Lab Med 2020; 2: 27-50.
30.
Mantzavinosa V, Alexiou AT, Greig NH,
Kamal MA. Biomarkers for Alzheimer’s
Disease Diagnosis. Curr Alzheimer Res 2017; 14: 1149–1154.
31.
Leuzy A, Carlgren NM, Palmqvist S, Janelidze S, Dage JL, Hansson O. Blood‐based
biomarkers for Alzheimer’s
disease. EMBO Mol Med 2022;14: e14408.
32.
Bagyinszky E, Youn YC, An SSA, Kim SY. The
genetics of Alzheimer’s
disease. Clin Interv Aging 2014; 9: 535-51.
33.
Rather MA, Khan A, Alshahrani S, Rashid H,
Qadri M, Rashid S, et, al. Inflammation and Alzheimer’s
Disease: Mechanisms and Therapeutic Implications by Natural Products. Mediators
Inflamm 2021; 2021: 1-21.
34.
Cedillo TJ, Jonas SD. Metabolic Syndrome
and Its Biomarkers in the Development and Progression of Alzheimer’s
Disease and Other Dementias. In book Advances in Dementia Research. Web of
Science 2018. Available from: https://www.intechopen.com/chapters/64316.
35.
Magisetty JO, Magisetty J, Magisetty D, Magisetty L.
Biomarkers of Alzheimer’s
disease: An overview of the recent inventions. Recent Patent on biomarkers
2013; 3: 184-187.
36.
Yiannopoulou KG, Papageorgiou SG. Current
and Future Treatments in Alzheimer Disease: An Update. ENT Nerv Syst Dis 2020;
12: 1-12.
37.
Huynh RA, Chandra M. Alzheimer’s
Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid. Front Neurol
2017; 8: 102.
38.
Grossberg GT. Diagnosis and treatment of
Alzheimer’s disease. J Clin
Psychiatry 2003:64 (Suppl 9): 3-6. Available from: https://pubmed.ncbi.nlm.nih.gov/12934967/.
39.
De A, Bala NN, Gupta PD. Alzheimer’s
Disease and its Management. IJRPBS 2011. 2: 1439-43.
40.
Bhushan I, Kour M, Kour G, Gupta S, Sharma
S, Yadav A. Alzheimer’s
disease: Causes & treatment –A
review. J. Biotech 2018; 1: 1-8.
41.
Delaby C, Gabelle A, Blum D, Maschke SS,
Moulinier A, Boulanghien J, et, al. Central Nervous System and Peripheral
Inflammatory Processes in Alzheimer’s
Disease: Biomarker Profiling Approach. Front. Neurol 2015; 6: 181.
42.
Mosconi L, Brys M, Glodzik-Sobanska L,
Santi S, Rusinek H, Leon M. Early detection of Alzheimer’s
disease using neuroimaging. Exp Gerontol 2007; 42: 129-38.
43.
Cummings J, Zhou Y, Lee G, Zhong K.
Alzheimer’s disease drug.
Development pipeline: 2023. Alzheimers Dement (N Y) 2023; 9: e12385.
44.
Buccellato FR, D’Anca
M, Tartaglia GM, Fabbro MD, Scarpini E, Galimberti D. Treatment of Alzheimer’s
Disease: Beyond Symptomatic Therapies. Int. J. Mol. Sci 2023; 24: 1-25.
45.
Nivetha S.R, Shivani K, Vigneshwaran R, Prasanna
G, Veeramani M. An overview on Alzheimer’s disease, diagnosis and treatment
approach. Int. J. of Allied Med. Sci. and Clin 2023; 11: 379-3911.
46.
Poudel. P, Park S. Recent Advances in the
Treatment of Alzheimer’s Disease Using Nanoparticle-Based Drug Delivery
Systems. Pharmaceutics 2022; 14: 1-38.
47.
Mirakhori F, Moafi M, Milanifard M, Rizi
AA, Tahernia H. Diagnosis and Treatment Methods in Alzheimer’s Patients Based
on Modern Techniques: The Original Article. Journal of Pharmaceutical Negative
Results 2022; 13: 1889-1907.
48.
Dakdareh SG, Abbasian K. Diagnosis of
Alzheimer’s Disease and Mild Cognitive Impairment Using Convolutional Neural
Networks. Journal of Alzheimer’s Disease Reports 2024; 8: 317-328.
49.
Daly T, Keuck L. Alzheimer’s Disease:
Engaging with an unstable category 2024. 2ndEd. Springer; 2025;P 1–24.
Available from: https://pubmed.ncbi.nlm.nih.gov/.
50.
Yap LE, Hunt JE and Turner RS. Aging as a
target for the prevention and treatment of Alzheimer’s disease. Frontiers in
Neurology 2024; 15: 1-7.
51.
Yoon C H, Groff C, Criss O. Lecanemab: A
Second in Class Therapy for the Management of Early Alzheimer’s Disease.
INNOVATIONS in pharmacy 2024; 15: 1-11.
52.
Li X, Ji M, Zhang H, Liu Z, Chai Z, Cheng
Q, Yue, et al. Non-drug Therapies for Alzheimer’s disease: A Review. Neurol
Ther 2022; 12: 39-72.
53.
Vu H T, Nguyen HT and Nguyen AT.
Effectiveness of Non-Pharmacological Interventions for Dementia among the
Elderly: A Randomized Controlled Trial. Geriatrics 2024; 9: 52.
54.
TTÜRKE H, ARSLAN ME, STEFANO AD, and
CACCIATORE I and MARDİNOĞLU A. Nonpharmacological treatment options for
Alzheimer’s disease: from animal testing to clinical studies. Turkish Journal
of Zoology 2020; 44: 81-89.
55.
Goorah S, Dorkhy GD. Non-Pharmacological
Management of Alzheimer's disease A Qualitative Study, In Mauritius.
Alzheimer’s and Dementia 2020; 16: e037199. Available from: https://www.medrxiv.org/content/10.1101/2020.01.25.20018747v1.full.
56.
Parikh NH, Parikh PK, Rao HJ, Shah K, Dave
BP, Prajapati BG. Current trends and updates in the treatment of Alzheimer’s
disease. Science Direct 2024; 373-390.
57. Smith B, Ownby RL. Disease-Modifying
Treatments and Their Future in Alzheimer’s disease Management. Cureus 2024; 13;
16(3):e56105.
58.
Thangwaritorn
S, Lee C, Metchikoff E, Razdan V,
Ghafary V, Rivera D, et al. A Review of
Recent Advances in the Management of Alzheimer’s Disease. Cureus 2024; 16(4):e58416.doi:
10.7759/cureus.58416. eCollection 2024 Apr.
Available from: https://pubmed.ncbi.nlm.nih.gov/38756263/.
59. Ahmad F, Karan A, Sharma R, Sharma NS, Sundar
V, Jayaraj R. Evolving therapeutic interventions for the management and
treatment of Alzheimer’s disease. Ageing Research Reviews 2024; 95: 102229.
Available from: https://pubmed.ncbi.nlm.nih.gov/38364913/.
60. Ain S, Betty P. and Pathak
K. Preformulative assessment of preformed complexes of gemfibrozil, with
cyclodextrins. PDA Journal of Pharmaceutical science and Technology. 2008; 62
(4): 300-308.
61.
Ali M, Ain S, Kumar B.
and Ain Q. Development and evaluation of eugenol-based gel formulation for
analgesic and anti-inflammatory action.
Annals of Phytomedicine. 2022, 11(1): 338-345.